Histamine H2 receptor antagonist exhibited comparable all-cause mortality-decreasing effect as β-blockers in critically ill patients with heart failure: a cohort study

MLA

Xue-Sha Zhang, et al. “Histamine H2 Receptor Antagonist Exhibited Comparable All-Cause Mortality-Decreasing Effect as β-Blockers in Critically Ill Patients with Heart Failure: A Cohort Study.” Frontiers in Pharmacology, vol. 14, Nov. 2023. EBSCOhost, https://doi.org/10.3389/fphar.2023.1273640.

APA

Xue-Sha Zhang, Wen-Ke Cai, Ping Wang, Ran Xu, Sun-Jun Yin, Yan-Hua Huang, Yu Guo, Fang-Fang Jiang, Jian-Mei Pan, Yi-Hua Li, & Gong-Hao He. (2023). Histamine H2 receptor antagonist exhibited comparable all-cause mortality-decreasing effect as β-blockers in critically ill patients with heart failure: a cohort study. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1273640

Chicago

Xue-Sha Zhang, Wen-Ke Cai, Ping Wang, Ran Xu, Sun-Jun Yin, Yan-Hua Huang, Yu Guo, et al. 2023. “Histamine H2 Receptor Antagonist Exhibited Comparable All-Cause Mortality-Decreasing Effect as β-Blockers in Critically Ill Patients with Heart Failure: A Cohort Study.” Frontiers in Pharmacology 14 (November). doi:10.3389/fphar.2023.1273640.